From: Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials
Effect | d = 1 Control | d = 2 2.60 | d = 3 4.17 | d = 4 5.40 | d = 5 5.92 | d = 6 6.20 | d = 7 7.76 | d = 8 9.52 |
---|---|---|---|---|---|---|---|---|
Large | 0.40 | 0.59 | 0.60 | 0.61 | 0.62 | 0.63 | 0.64 | 0.65 |
NBH | 0.40 | 0.40 | 0.40 | 0.70 | 0.40 | 0.70 | 0.70 | 0.70 |
Over Dose | 0.40 | 0.40 | 0.50 | 0.55 | 0.70 | 0.40 | 0.35 | 0.30 |